Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis

被引:37
|
作者
Muratore, Francesco [1 ]
Boiardi, Luigi [1 ]
Cavazza, Alberto [2 ]
Aldigeri, Raffaella [3 ]
Pipitone, Nicolo [1 ]
Restuccia, Giovanna [1 ]
Bellafiore, Salvatore [2 ]
Cimino, Luca [4 ]
Salvarani, Carlo [1 ]
机构
[1] Azienda Osped ASMN, Ist Ricovero & Cura Carattere Sci, Dept Internal Med, Rheumatol Unit, Reggio Emilia, Italy
[2] Azienda Osped ASMN, Ist Ricovero & Cura Carattere Sci, Dept Oncol, Pathol Unit, Reggio Emilia, Italy
[3] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy
[4] Azienda Osped ASMN, Ist Ricovero & Cura Carattere Sci, Dept Surg, Ophthalmol Unit, Reggio Emilia, Italy
关键词
Temporal artery biopsy; Giant cell arteritis; Temporal arteritis; Visual loss; Ischemic complications; Histopathology; Colour duplex ultrasonography; POPULATION-BASED COHORT; TEMPORAL ARTERITIS; RISK-FACTORS; ISCHEMIC COMPLICATIONS; POLYMYALGIA-RHEUMATICA; VISUAL-LOSS; INTIMAL HYPERPLASIA; ANGIOGENIC ACTIVITY; FEATURES; PATTERNS;
D O I
10.1016/j.jaut.2016.03.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To correlate histopathological features of positive temporal artery biopsy (TAB) and clinical manifestations of the disease in a large single-center population-based cohort of patients with biopsy proven giant cell arteritis (GCA). Methods: A pathologist with expertise in vasculitis and blinded to clinical data and final diagnosis reviewed all TABs performed for suspected GCA at our hospital between January 1986 and December 2013. Histopathologic features evaluated were: the severity of inflammation and intimal hyperplasia, both graded on a semiquantitative scale (mild = 1, moderate = 2, severe = 3), the presence of intraluminal acute thrombosis, calcifications, giant cells, fibrinoid necrosis and laminar necrosis. Results: 274 patients had a final diagnosis of biopsy-proven GCA and were included in the study. Cranial ischemic events (CIEs) were observed in 161 (58.8%), visual manifestations in 79 (28.8%) and permanent (partial or complete) visual loss in 51 (18.6%) patients. Predictors for the development of CIEs were older age (OR = 1.057, 95% CI 1.019-1.097, p = 0.003), lower ESR values (OR = 0.990, 95% CI 0.981-0.999, p = 0.026) as well as the presence of giant cells (OR = 1.848, 95% CI 1.045-3.269, p = 0.035) and laminar necrosis at TAB (OR = 2.334, 95% CI 1.187-4.587, p = 0.014). Predictors for the development of permanent visual loss were lower CRP values (OR = 0.906, 95% CI 0.827-0.992, p = 0.033) and the presence of calcifications at TAB (OR = 3.672, 95% CI 1.479-9.121, p = 0.005). Fibrinoid necrosis was not observed in any of the TABs evaluated. Conclusion: Pathological features of TAB may predict some manifestations of GCA. These findings may have implications for patients' management. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:94 / 101
页数:8
相关论文
共 50 条
  • [21] Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis
    Font, C
    Cid, MC
    CollVinent, B
    LopezSoto, A
    Grau, JM
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (02): : 251 - 254
  • [22] CLINICAL AND LABORATORY CHARACTERISTICS ASSOCIATED WITH VISUAL COMPLICATIONS IN PATIENTS WITH BIOPSY-PROVEN GIANT CELL ARTERITIS
    Saleh, M.
    Turesson, C.
    Englund, M.
    Merkel, P. A.
    Mohammad, A. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 695 - 695
  • [23] Clinical and laboratory characteristics associated with visual complications in patients with biopsy-proven giant cell arteritis
    Saleh, M.
    Turesson, C.
    Englund, M.
    Merkel, P. A.
    Mohammad, A. J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 48 - 49
  • [24] Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis
    Palomino-Morales, Rogelio J.
    Vazquez-Rodriguez, Tomas R.
    Torres, Orlando
    Morado, Inmaculada C.
    Castaneda, Santos
    Miranda-Filloy, Jose A.
    Callejas-Rubio, Jose L.
    Fernandez-Gutierrez, Benjamin
    Gonzalez-Gay, Miguel A.
    Martin, Javier
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
  • [25] Association between IL-18gene polymorphisms and biopsy-proven giant cell arteritis
    Rogelio J Palomino-Morales
    Tomas R Vazquez-Rodriguez
    Orlando Torres
    Inmaculada C Morado
    Santos Castañeda
    Jose A Miranda-Filloy
    Jose L Callejas-Rubio
    Benjamin Fernandez-Gutierrez
    Miguel A Gonzalez-Gay
    Javier Martin
    Arthritis Research & Therapy, 12
  • [26] Relapse Characteristics and Glucocorticoid Use in Patients with Biopsy-Proven Giant Cell Arteritis
    Koster, Matthew J.
    Labarca, Cristian
    Crowson, Cynthia S.
    Makol, Ashima
    Ytterberg, Steven R.
    Matteson, Eric L.
    Warrington, Kenneth J.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [27] FREQUENCY AND PREDICTIVE VARIABLES OF RELAPSES IN PATIENTS WITH BIOPSY-PROVEN GIANT CELL ARTERITIS
    Restuccia, G.
    Boiardi, L.
    Muratore, F.
    Cavazza, A.
    Cimino, L.
    Aldigeri, R.
    Macchioni, P.
    Catanoso, M. G.
    Pipitone, N.
    Salvarani, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 160 - 160
  • [28] Mortality in giant cell arteritis: analysis of a monocentric cohort of biopsy-proven patients
    Talarico, R.
    Figus, M.
    D'Ascanio, A.
    Stagnaro, C.
    Ferrari, C.
    Elefante, E.
    Tani, C.
    Baldini, C.
    Mosca, M.
    Bombardieri, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (01) : S90 - S90
  • [29] Horner Syndrome and Internuclear Ophthalmoplegia Due to Biopsy-Proven Giant Cell Arteritis
    Kang, Tony
    Patil, Gauri
    Williams, Zoe R.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2024, 44 (01) : e134 - e135
  • [30] Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden
    Mohammad, Aladdin J.
    Nilsson, Jan-Ake
    Jacobsson, Lennart T. H.
    Merkel, Peter A.
    Turesson, Carl
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 993 - 997